These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 24467910)

  • 21. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.
    Ukichi T; Yoshida K; Matsushima S; Kawakami G; Noda K; Furuya K; Kurosaka D
    RMD Open; 2019; 5(1):e000850. PubMed ID: 30997152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermatomyositis: clinicopathological correlations.
    Sena P; Gianatti A; Gambini D
    G Ital Dermatol Venereol; 2018 Apr; 153(2):256-264. PubMed ID: 29368856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
    Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
    Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCɛ.
    Inoue K; Jinnin M; Yamane K; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Fukushima S; Ihn H
    Eur J Dermatol; 2013 Apr; 23(2):160-7. PubMed ID: 23557915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis?
    Takahashi Y; Murota H; Tarutani M; Sano S; Okinaga T; Tominaga K; Yano T; Katayama I
    Allergol Int; 2010 Dec; 59(4):425-8. PubMed ID: 20962570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants.
    Didona D; Juratli HA; Scarsella L; Eming R; Hertl M
    Eur J Dermatol; 2020 Jun; 30(3):229-242. PubMed ID: 32666925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.
    Udkoff J; Cohen PR
    Am J Clin Dermatol; 2016 Oct; 17(5):509-518. PubMed ID: 27256496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification criteria for polymyositis and dermatomyositis.
    Tanimoto K; Nakano K; Kano S; Mori S; Ueki H; Nishitani H; Sato T; Kiuchi T; Ohashi Y
    J Rheumatol; 1995 Apr; 22(4):668-74. PubMed ID: 7791161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria.
    Concha JSS; Tarazi M; Kushner CJ; Gaffney RG; Werth VP
    Br J Dermatol; 2019 May; 180(5):1001-1008. PubMed ID: 30561064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-MDA5 dermatomyositis. Literature review].
    Castro-Molina SA; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):99-105. PubMed ID: 36542793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification criteria for the idiopathic inflammatory myopathies.
    Targoff IN; Miller FW; Medsger TA; Oddis CV
    Curr Opin Rheumatol; 1997 Nov; 9(6):527-35. PubMed ID: 9375282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic inflammatory myopathies.
    van der Kooi AJ; de Visser M
    Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasciitis in amyopathic dermatomyositis.
    Allen E; Schmahmann S; Sauser D; Barkhuizen A
    J Clin Rheumatol; 2003 Feb; 9(1):51-3. PubMed ID: 17041424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulcerative Heliotrope Rash in Antimelanoma Differentiation-Associated Gene 5 Dermatomyositis.
    Daugherty TT; Cheeley JT
    Cutis; 2021 May; 107(5):E5-E8. PubMed ID: 34288860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatomyositis: Clinical features and pathogenesis.
    DeWane ME; Waldman R; Lu J
    J Am Acad Dermatol; 2020 Feb; 82(2):267-281. PubMed ID: 31279808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis.
    Park JH; Olsen NJ; King L; Vital T; Buse R; Kari S; Hernanz-Schulman M; Price RR
    Arthritis Rheum; 1995 Jan; 38(1):68-77. PubMed ID: 7818575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.